Recent Finacing
Recent Raise
Cysal, a 2012 biotech spin-off, operates a patented industrial bioprocess manufacturing arginine-aspartate and lysine-aspartate dipeptides and formulates them into energy tonics, skin creams, fish feed additives, and infusions.
Focus Areas
Recent Investors
Funding round
Investors